Training overview
COURSE NUMBER: WB4835
PROGRAM DESCRIPTION: The Malaria 101 for the Healthcare Provider course is a web-based training course designed to teach epidemiologists and healthcare professionals about the epidemiology, prevention, diagnosis, and treatment of malaria. Lesson 1 provides some background on malaria and discusses the epidemiology of malaria. Lesson 2 discusses the prevention of malaria in travelers. Lesson 3 reviews the diagnosis and treatment of malaria. After the lessons, three clinical scenarios will be presented. Content is derived from actual knowledge and practices.
OBJECTIVES:
At the conclusion of the session, the participant should be able to:
- Describe malaria disease epidemiology.
- Describe how to manage a patient during the pre-travel consultation to prevent malaria using CDC guidelines for malaria chemoprophylaxis.
- Describe how to diagnose malaria using current CDC recommendations.
- Describe how to treat malaria using current CDC recommendations.
- Describe how interprofessional collaboration is necessary in the diagnosis of malaria.
FACULTY/ CREDENTIALS:
Chang, Michelle
MD, Medical Epidemiologist, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria
Ridpath, Alison
MD, MPH, Medical Epidemiologist, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria
Williams, Seymour
MD, MPH, Medical Epidemiologist, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria
CE ORIGINATION DATE: May 31, 2024
CE EXPIRATION DATE: May 31, 2026
URL: https://www.cdc.gov/malaria/cme/index.html
HARDWARE/SOFTWARE: Computer hardware; Internet connection; Browser
MATERIALS: Computer hardware; Internet connection; Browser
TARGET AUDIENCE: Physicians (DO, MD), Registered Nurses, Licensed Practical/Vocational Nurses, Physicians Assistants
PREREQUISITES: General clinical knowledge to evaluate, diagnose, and treat patients in the United States.
FORMAT: This activity is Web based
CONTACT INFORMATION: CDC Malaria Hotline during business hours; (770) 488-7788, 9am–5pm ET, Mon. – Fri.
ACCREDITATION STATEMENTS
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Enduring Materials
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 05/31/2026. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Alison Ridpath, MD, MPH’s discussion/content. Her content that will be included in this training will be information on tafenoquine which is FDA approved to eradicate P. vivax hypnozoites. Its use for P. ovale hypnozoites is an off-label indication and is noted in the presentation.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
INSTRUCTIONS FOR OBTAINING CONTINUING EDUCATION (CE)
To receive continuing education (CE) for WB4835-Malaria 101 for the Healthcare Provider, please visit CDC TRAIN and search for the course in the Course Catalog using WB4835. Follow the steps below by 05.31.2026.
- Register for and complete the course.
- Pass the post-assessment at 70%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
FEES: No fees are charged for CDC's CE activities.